Cwm LLC Has $63,000 Stock Position in Cabot Co. (NYSE:CBT)

Cwm LLC lifted its holdings in shares of Cabot Co. (NYSE:CBT) by 35.6% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 564 shares of the specialty chemicals company’s stock after buying an additional 148 shares during the period. Cwm LLC’s holdings in Cabot were worth $63,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of the business. EverSource Wealth Advisors LLC increased its stake in shares of Cabot by 33.4% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 475 shares of the specialty chemicals company’s stock worth $48,000 after purchasing an additional 119 shares during the last quarter. Miller Howard Investments Inc. NY boosted its holdings in shares of Cabot by 4.4% during the 2nd quarter. Miller Howard Investments Inc. NY now owns 3,162 shares of the specialty chemicals company’s stock worth $291,000 after buying an additional 132 shares during the period. Mercer Global Advisors Inc. ADV boosted its holdings in shares of Cabot by 0.4% during the 2nd quarter. Mercer Global Advisors Inc. ADV now owns 42,185 shares of the specialty chemicals company’s stock worth $3,876,000 after buying an additional 162 shares during the period. Acadian Asset Management LLC boosted its holdings in shares of Cabot by 8.8% during the 1st quarter. Acadian Asset Management LLC now owns 2,464 shares of the specialty chemicals company’s stock worth $226,000 after buying an additional 199 shares during the period. Finally, State of Michigan Retirement System boosted its holdings in shares of Cabot by 2.3% during the 1st quarter. State of Michigan Retirement System now owns 13,565 shares of the specialty chemicals company’s stock worth $1,251,000 after buying an additional 300 shares during the period. Institutional investors and hedge funds own 93.18% of the company’s stock.

Cabot Trading Down 1.0 %

Shares of Cabot stock opened at $109.26 on Monday. The company has a quick ratio of 1.45, a current ratio of 2.22 and a debt-to-equity ratio of 0.72. The stock has a market capitalization of $6.04 billion, a P/E ratio of 13.83, a price-to-earnings-growth ratio of 0.93 and a beta of 1.19. Cabot Co. has a 12-month low of $65.10 and a 12-month high of $117.14. The company has a 50-day simple moving average of $107.40 and a 200 day simple moving average of $100.31.

Cabot (NYSE:CBT) last posted its quarterly earnings data on Monday, August 5th. The specialty chemicals company reported $1.92 earnings per share for the quarter, beating the consensus estimate of $1.72 by $0.20. The firm had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1 billion. Cabot had a net margin of 12.05% and a return on equity of 26.99%. The company’s quarterly revenue was up 5.0% compared to the same quarter last year. During the same quarter last year, the company posted $1.42 EPS. Research analysts expect that Cabot Co. will post 7.07 earnings per share for the current fiscal year.

Insider Activity

In other news, CFO Erica Mclaughlin sold 23,274 shares of the firm’s stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $99.79, for a total value of $2,322,512.46. Following the transaction, the chief financial officer now owns 59,814 shares of the company’s stock, valued at approximately $5,968,839.06. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In related news, CFO Erica Mclaughlin sold 23,274 shares of Cabot stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $99.79, for a total transaction of $2,322,512.46. Following the transaction, the chief financial officer now owns 59,814 shares of the company’s stock, valued at $5,968,839.06. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Hobart Kalkstein sold 5,457 shares of Cabot stock in a transaction that occurred on Tuesday, August 20th. The stock was sold at an average price of $100.58, for a total transaction of $548,865.06. Following the transaction, the executive vice president now directly owns 61,688 shares in the company, valued at $6,204,579.04. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 71,939 shares of company stock valued at $7,308,812. 3.07% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several analysts recently issued reports on the stock. UBS Group decreased their price objective on shares of Cabot from $103.00 to $98.00 and set a “neutral” rating for the company in a report on Tuesday, August 6th. JPMorgan Chase & Co. increased their price target on shares of Cabot from $95.00 to $105.00 and gave the company a “neutral” rating in a report on Wednesday, August 7th. Three analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $101.75.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.